Healixa Financials
| EMOR Stock | USD 0.06 0.01 18.00% |
Healixa |
Understanding current and past Healixa Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Healixa's financial statements are interrelated, with each one affecting the others. For example, an increase in Healixa's assets may result in an increase in income on the income statement.
Healixa Stock Summary
Healixa competes with CareCloud, Vitalhub Corp, Pharma-Bio Serv, CareMax, and Premier. Healixa Inc. operates as a technology company with assets in both healthtech and fintech. The company was founded in 1977 and is based in Holbrook, New York. Healixa operates under Health Information Services classification in the United States and is traded on OTC Exchange.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 331 Dante Court, |
| Sector | Healthcare |
| Industry | Health Information Services |
| Benchmark | Dow Jones Industrial |
| Website | healixa.com |
| Phone | 855 432 5492 |
| Currency | USD - US Dollar |
Healixa Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Healixa's current stock value. Our valuation model uses many indicators to compare Healixa value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Healixa competition to find correlations between indicators driving Healixa's intrinsic value. More Info.Healixa is one of the top stocks in shares outstanding category among its peers. It also is one of the top stocks in number of employees category among its peers . The ratio of Shares Outstanding to Number Of Employees for Healixa is about 25,997,035 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Healixa's earnings, one of the primary drivers of an investment's value.Healixa Systematic Risk
Healixa's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Healixa volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Healixa correlated with the market. If Beta is less than 0 Healixa generally moves in the opposite direction as compared to the market. If Healixa Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Healixa is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Healixa is generally in the same direction as the market. If Beta > 1 Healixa moves generally in the same direction as, but more than the movement of the benchmark.
Healixa November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Healixa help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Healixa. We use our internally-developed statistical techniques to arrive at the intrinsic value of Healixa based on widely used predictive technical indicators. In general, we focus on analyzing Healixa Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Healixa's daily price indicators and compare them against related drivers.
| Downside Deviation | 19.65 | |||
| Information Ratio | 0.1028 | |||
| Maximum Drawdown | 115.0 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 25.0 |
Additional Tools for Healixa Pink Sheet Analysis
When running Healixa's price analysis, check to measure Healixa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Healixa is operating at the current time. Most of Healixa's value examination focuses on studying past and present price action to predict the probability of Healixa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Healixa's price. Additionally, you may evaluate how the addition of Healixa to your portfolios can decrease your overall portfolio volatility.